Compare · 2 funds side by side · dividends reinvested

LABD and VIG

LABDDirexion×VIGVanguard×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$16,495VIG · best of the two

02 / 04

LABD and VIG, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Vanguard Dividend Appreciation ETFIncome · Dividend stocks0.04%1.47%+14.0%+15.9%+20.2%+10.5%−7.9%10.0%$109B1.1

Direxion Daily S&P Biotech Bear 3X ETFLeveraged · 3x1.08%6.50%−65.7%−73.9%−70.1%−48.2%−81.0%88.4%$82M1.9

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: LABD 2015 · VIG 2006

Head to Head

Swap sides Versus in desk

Head to Head

Direxion Daily S&P Biotech Bear 3X ETF · $82M$268

LABD

VIG

Vanguard Dividend Appreciation ETF · $109B$17,369

$10,000 three years ago, dividends reinvested

LABDMeasureVIG

−65.7%Year to dateJan 1 → Nov 3+14.0%

−73.9%1 yearTotal return+15.9%

−70.1%3 years · per year$10,000 became $268 · $17,369+20.2%

−48.2%5 years · per year$10,000 became $372 · $16,495+10.5%

1.08%Expense ratio$108 · $4 a year on $10k · lower is better0.04%

6.50%Trailing 12-mo yield$650 · $147 a year on $10k1.47%

−81.0%Worst dropSmaller is better−7.9%

88.4%VolatilityLower is calmer10.0%

LABDVIG Winner of the row, in its colourEach row: the bigger of the two fills its side

1–7VIG wins

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

LABD vs VIG: Top 5 Holdings

Today

LABD

[…]in top 5

VIG

in top 522.1%

LABDStockVIG

not top 5MSFT4.9%

not top 5AAPL4.9%

not top 5AVGO4.3%

not top 5LLY4.1%

not top 5JPM3.9%

Held in common[…]

End-of-day Nov 3, 2026 · share of each fund

LABD vs VIG Returns, Every Period

DirexionLABD

−48.2%

5 years, per year

VIGVanguard

+10.5%

5 years, per year

LABDVIGFaded: behind in that period

0–4VIG wins

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

Leveraged vs Income: LABD vs VIG

YTD

DirexionLABD

−65.7%

VIGVanguard

+14.0%

−65.7%Year to date+14.0%

−81.0%Worst drop · 1Y−7.9%

88.4%Volatility · 1Y10.0%

6.5%Yield1.5%

$81.5MAssets$109B

3–1VIG wins

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: LABD, VIG

Today

0.04%lowest, VIG

FundExpense ratioFee$10k

VIG0.04%$4

LABD1.08%$108

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: LABD, VIG

6.50%highest, LABD

FundTrailing yieldYield$10k

LABD6.50%$650

VIG1.47%$147

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

$542most kept, LABD

LABD$650 − $108 = $542

VIG$147 − $4 = $143

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: LABD, VIG

Today

[…]holdings […]

LABDVIG

LABD—[…]

VIG[…]—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+15.9%VIG, at 10.0% volatility

VIGWorst drop−7.9%10.0% vol

LABDWorst drop−81.0%88.4% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

LABDVIG

−65.7%Year to date+14.0%

6.5%Yield1.5%

−73.9%Past year+15.9%

1.08%Fee0.04%

3–1VIG wins

End-of-day Nov 3, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026

DGRO vs VIG

YTD

iSharesDGRO

+18.0%

VIGVanguard

+14.0%

+18.0%Year to date+14.0%

1.8%Yield1.5%

$45.1BAssets$109B

2–0DGRO wins

End-of-day Nov 3, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.5%

JEPIJ.P. Morgan

+7.0%

+7.5%Year to date+7.0%

12.3%Yield8.0%

$41.8BAssets$46.0B

2–0JEPQ wins

End-of-day Nov 3, 2026